A critical review of talc and ovarian cancer

References

• American Cancer Society (ACS). 2019. Ovarian cancer. https://www.cancer.org/cancer/ovarian-cancer.html.
   Google Scholar
• American Conference of Governmental Industrial Hygienists (ACGIH). 2010. Documentation for talc (CAS No. 14807-96-6). In Documentation of the threshold limit values and biological exposure indices, 7th ed., 12. Cincinnati, OH: American Conference of Governmental Industrial Hygienists (ACGIH).
   Google Scholar
• Baiu, I., E. Yevudza, and J. B. Shrager. 2019. Talc pleurodesis: A medical, medicolegal, and socioeconomic review. Ann. Thorac. Surg. doi:10.1016/j.anthroacsur.2019.08.104.
   PubMed Web of Science ®Google Scholar
• Boffetta, P., J. K. McLaughlin, C. La Vecchia, R. E. Tarone, L. Lipworth, and W. J. Blot. 2008. False-positive results in cancer epidemiology: A plea for epistemological modesty. J. Natl. Cancer Inst. 100:988–95. doi:10.1093/jnci/djn191.
   PubMed Web of Science ®Google Scholar
• Boffetta, P., K. A. Mundt, and W. J. Thompson. 2018. The epidemiologic evidence for elongate mineral particle (EMP)-related human cancer risk. Toxicol. Appl. Pharmacol. 361:100–06. doi:10.1016/j.taap.2018.09.021.
   PubMed Web of Science ®Google Scholar
• Boorman, G. A., and J. C. Seely. 1995. The lack of an ovarian effect of lifetime talc exposure in F344/N rats and B6C3F1 mice. Regul. Toxicol. Pharmacol. 2:242–43. doi:10.1006/rtph.1995.1035.
   Google Scholar
• Booth, M., V. Beral, and P. Smith. 1989. Risk factors for ovarian cancer: A case-control study. Br. J. Cancer 60:592–98. doi:10.1038/bjc.1989.320.
   PubMed Web of Science ®Google Scholar
• Buz’Zard, A. R., and B. H. Lau. 2007. Pycnogenol reduces talc-induced neoplastic transformation in human ovarian cell cultures. Phytother. Res. 21:579–86. doi:10.1002/ptr.2117.
   PubMed Web of Science ®Google Scholar
• Carr, C. J. 1995. Talc: Consumer uses and health perspectives. Regul. Toxicol. Pharmacol. 21:211–15. doi:10.1006/rtph.1995.1030.
   PubMed Web of Science ®Google Scholar
• Celsi, F., S. Crovella, R. R. Moura, M. Schneider, F. Vita, L. Finotto, G. Zabucchi, P. Zacchi, and V. Borelli. 2019. Pleural mesothelioma and lung cancer: The role of asbestos exposure and genetic varants in selected iron metabolism and inflammation genes. J. Toxicol. Environ. Health Part A 82:1088–102. doi:10.1080/15287394.2019.1694612.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). 2015. What are the risk factors for ovarian cancer? December 8. https://www.cdc.gov/cancer/ovarian/basic_info/risk_factors.htm
   Google Scholar
• Centers for Disease Control and Prevention (CDC). 2016. NIOSH pocket guide to chemical hazards record for talc (containing no asbestos and less than 1% quartz) (CAS No. 14807-96-6). April 11. https://www.cdc.gov/niosh/npg/npgd0584.html.
   Google Scholar
• Chang, S., and H. A. Risch. 1997. Perineal talc exposure and risk of ovarian carcinoma. Cancer 79:2396–401. doi:10.1002/(SICI)1097-0142(19970615)79:12<2396::AID-CNCR15>3.0.CO;2-M.
   PubMed Web of Science ®Google Scholar
• Chatfield, E. J. 2018. Measurement of elongate mineral particles: What we should measure and how do we do it? Toxicol. Appl. Pharmacol. 361:36–46. doi:10.1016/j.taap.2018.08.010.
   PubMed Web of Science ®Google Scholar
• Chen, Y., P. C. Wu, J. H. Lang, W. J. Ge, P. Hartge, and L. A. Brinton. 1992. Risk factors for epithelial ovarian cancer in Beijing, China. Int. J. Epidemiol. 21:23–29. doi:10.1093/ije/21.1.23.
   PubMed Web of Science ®Google Scholar
• Cook, L. S., M. L. Kamb, and N. S. Weiss. 1997. Perineal powder exposure and the risk of ovarian cancer. Am. J. Epidemiol. 145:459–65. doi:10.1093/oxfordjournals.aje.a009128.
   PubMed Web of Science ®Google Scholar
• Coultas, D. B., C. A. Howard, G. T. Peake, B. J. Skipper, and J. M. Samet. 1988. Discrepancies between self-reported smoking and validated cigarette smoking in a community survey of New Mexico Hispanics. Am. Rev. Respir. Dis. 137:810–14. doi:10.1164/ajrccm/137.4.810.
   PubMed Web of Science ®Google Scholar
• Cramer, D. W. 2012. The epidemiology of endometrial and ovarian cancer. Hematol. Oncol. Clin. North Am. 26:1–12. doi:10.1016/j.hoc.2011.10.009.
   PubMed Web of Science ®Google Scholar
• Cramer, D. W., and O. J. Finn. 2011. Epidemiologic perspective on immune-surveillance in cancer. Curr. Opin. Immunol. 23:265–71. doi:10.1016/j.coi.2011.01.002.
   PubMed Web of Science ®Google Scholar
• Cramer, D. W., R. F. Liberman, L. Titus-Ernstoff, W. R. Welch, E. R. Greenberg, J. A. Baron, and B. L. Harlow. 1999. Genital talc exposure and risk of ovarian cancer. Int. J. Cancer 81:351–56. doi:10.1002/(SICI)1097-0215(19990505)81:3<351::AID-IJC7>3.0.CO;2-M.
   PubMed Web of Science ®Google Scholar
• Cramer, D. W., A. F. Vitonis, K. L. Terry, W. R. Welch, and L. J. Titus. 2016. The association between talc use and ovarian cancer: A retrospective case-control study in two US states. Epidemiology 27:334–46. doi:10.1097/EDE.0000000000000434.
   PubMed Web of Science ®Google Scholar
• Cramer, D. W., W. R. Welch, R. S. Berkowitz, and J. J. Godleski. 2007. Presence of talc in pelvic lymph nodes of a woman with ovarian cancer and long-term genital exposure to cosmetic talc. Obstet. Gynecol. 110:498–501. doi:10.1097/01.AOG.0000262902.80861.a0.
   PubMed Web of Science ®Google Scholar
• Cramer, D. W., W. R. Welch, R. E. Scully, and C. A. Wojciechowski. 1982. Ovarian cancer and talc: A case-control study. Cancer 50:372–76. doi:10.1002/1097-0142(19820715)50:2<372::AID-CNCR2820500235>3.0.CO;2-S.
   PubMed Web of Science ®Google Scholar
• Cramer, D. W., and H. Xu. 1995. Epidemiologic evidence for uterine growth factors in the pathogenesis of ovarian cancer. Ann. Epidemiol. 5:310–14. doi:10.1016/1047-2797(94)00098-E.
   PubMedGoogle Scholar
• Crane, D. T. 2018. OSHA and elongate mineral particles. Toxicol. Appl. Pharmacol. 361:165–67. doi:10.1016/j.taap.2018.08.017.
   PubMed Web of Science ®Google Scholar
• De Boer, C. H. 1972. Transport of particulate matter through the human female genital tract. J. Reprod. Fertil. 28:295–97. doi:10.1530/jrf.0.0280295.
   PubMedGoogle Scholar
• de Brito, T., and M. F. Franco. 1994. Granulomatous inflammation. Rev. Inst. Med. Trop. Sao Paulo 36:185–92. doi:10.1590/s0036-46651994000200016.
   PubMedGoogle Scholar
• Dodson, R. F. 2016. Preface: Respirable elongated mineral partices and human health-revisited. J. Toxicol Environ. Health B 19:149–50. doi:10.1080/10937404.2016.1193358.
   PubMed Web of Science ®Google Scholar
• Edelstam, G. A., A. C. Sjosten, and H. Ellis. 1997. Retrograde migration of starch in the genital tract of rabbits. Inflammation 21:489–99. doi:10.1023/A:1027307612999.
   PubMed Web of Science ®Google Scholar
• Egli, G. E., and M. Newton. 1961. The transport of carbon particles in the human female reproductive tract. Fertil. Steril. 12:151–55. doi:10.1016/S0015-0282(16)34084-5.
   PubMed Web of Science ®Google Scholar
• Endo-Capron, S., A. Renier, X. Janson, L. Kheuang, and M. C. Jaurand. 1993. In vitro response of rat pleural mesothelial cells to talc samples in genotoxicity assays (sister chromatid exchanges and DNA repair). Toxicol. In Vitro 7:7–14. doi:10.1016/0887-2333(93)90107-G.
   PubMed Web of Science ®Google Scholar
• Engel, L. S., N. S. Seixas, M. C. Keifer, W. T. Longstreth Jr., and H. Checkoway. 2001. Validity study of self-reported pesticide exposure among orchardists. J. Expo. Anal. Environ. Epidemiol. 11:359–68. doi:10.1038/sj.jea.7500176.
   PubMedGoogle Scholar
• Fiume, M. M., I. Boyer, W. Bergfeld, D. V. Belsito, C. D. Klaassen, D. C. Liebler, J. G. Marks Jr., R. C. Shank, T. J. Slaga, P. W. Snyder, et al. 2015. Safety assessment of talc as used in cosmetics. Int. J. Toxicol 34 (Suppl. 1):66S–129S. doi:10.1177/1091581815586797.
   PubMedGoogle Scholar
• Fletcher, N. M., A. K. Harper, I. Memaj, R. Fan, R. T. Morris, and G. M. Saed. 2019. Molecular basis supporting the association of talcum powder use with increased risk of ovarian cancer. Reprod. Sci. doi:10.1177/1933719119831773.
   Web of Science ®Google Scholar
• Friemann, J., C. Albrecht, P. Breuer, R. Grover, and C. Weishaupt. 1999. Time-course analysis of type II cell hyperplasia and alveolar bronchiolization in rats treated with different particulates. Inhal. Toxicol. 11:837–54. doi:10.1080/089583799196763.
   PubMed Web of Science ®Google Scholar
• Gabriel, I. M., A. F. Vitonis, W. R. Welch, L. Titus, and D. W. Cramer. 2019. Douching, talc use, and risk for ovarian cancer and conditions related to genital tract inflammation. Cancer Epidemiol. Biomarkers Prev. 28 (11):1835–44. doi:10.1158/1055-9965.EPI-19-0375.
   PubMed Web of Science ®Google Scholar
• Garabrant, D. H., and S. T. Pastula. 2018. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans. Toxicol. Appl. Pharmacol. 361:127–36. doi:10.1016/j.taap.2018.07.003.
   PubMed Web of Science ®Google Scholar
• Gates, M. A., B. A. Rosner, J. L. Hecht, and S. S. Tworoger. 2010. Risk factors for epithelial ovarian cancer by histologic subtype. Am. J. Epidemiol. 171:45–53. doi:10.1093/aje/kwp314.
   PubMed Web of Science ®Google Scholar
• Gates, M. A., S. S. Tworoger, K. L. Terry, L. Titus-Ernstoff, B. Rosner, I. De Vivo, D. W. Cramer, and S. E. Hankinson. 2008. Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer. Cancer Epidemiol. Biomarkers Prev. 17:2436–44. doi:10.1158/1055-9965.EPI-08-0399.
   PubMed Web of Science ®Google Scholar
• Gertig, D. M., D. J. Hunter, D. W. Cramer, G. A. Colditz, F. E. Speizer, W. C. Willett, and S. E. Hankinson. 2000. Prospective study of talc use and ovarian cancer. J. Natl. Cancer Inst. 92:249–52. doi:10.1093/jnci/92.3.249.
   PubMedGoogle Scholar
• Godard, B., W. D. Foulkes, D. Provencher, J. S. Brunet, P. N. Tonin, A. M. Mes-Masson, S. A. Narod, and P. Ghadirian. 1998. Risk factors for familial and sporadic ovarian cancer among French Canadians: A case-control study. Am. J. Obstet. Gynecol. 179:403–10. doi:10.1016/S0002-9378(98)70372-2.
   PubMed Web of Science ®Google Scholar
• Gonzalez, N. L., K. M. O’Brien, A. A. D’Aloisio, D. P. Sandler, and C. R. Weinberg. 2016. Douching, talc use, and risk of ovarian cancer. Epidemiology 27:797–802. doi:10.1097/EDE.0000000000000528.
   PubMed Web of Science ®Google Scholar
• Goodman, J., and H. Lynch. 2017. Improving the international agency for research on cancer’s consideration of mechanistic evidence. Toxicol. Appl. Pharmacol. 319:39–46. doi:10.1016/j.taap.2017.01.020.
   PubMed Web of Science ®Google Scholar
• Goodman, J. I. 1995. An analysis of the national toxicology program’s (NTP) technical report NTP TR 421) on the toxicology and carcinogenesis studies of talc. Regul.Toxicol. Pharmacol. 21:244–49. doi:10.1006/rtph.1995.1036.
   PubMed Web of Science ®Google Scholar
• Green, A., D. Purdie, C. Bain, V. Siskind, P. Russell, M. Quinn, and B. Ward. 1997. Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of women’s health study group. Int. J. Cancer 71:948–51. doi:10.1002/(SICI)1097-0215(19970611)71:6<948::AID-IJC6>3.0.CO;2-Y.
   PubMed Web of Science ®Google Scholar
• Greenland, S., and T. L. Lash. 2008. Bias analysis. In Modern epidemiology, ed. K. J. Rothman, S. Greenland, and T. L. Lash, 345–80. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins.
   Google Scholar
• Greenland, S., and K. O’Rourke. 2008. Meta-analysis. In Modern epidemiology, ed. K. J. Rothman, S. Greenland, and T. L. Lash, 652–82. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins.
   Google Scholar
• Gross, A. J., and P. H. Berg. 1995. A meta-analytical approach examining the potential relationship between talc exposure and ovarian cancer. J. Expo. Anal. Environ. Epidemiol. 5:181–95.
   PubMedGoogle Scholar
• Gunter, M. E. 2018. Elongate mineral particles in the natural environment. Toxicol.Appl. Pharmacol. 361:157–64. doi:10.1016/j.taap.2018.09.024.
   PubMed Web of Science ®Google Scholar
• Hamilton, T. C., H. Fox, C. H. Buckley, W. J. Henderson, and K. Griffiths. 1984. Effects of talc on the rat ovary. Br. J. Exp. Pathol. 65:101–06.
   PubMedGoogle Scholar
• Hankinson, S. E., and K. N. Danforth. 2006. Ovarian cancer. In Cancer epidemiology and prevention, ed. D. Schottenfeld, and J. F. Fraumeni, 1013–26. 3rd ed. New York: Oxford University Press.
   Google Scholar
• Harlow, B. L., D. W. Cramer, D. A. Bell, and W. R. Welch. 1992. Perineal exposure to talc and ovarian cancer risk. Obstet. Gynecol. 80:19–26.
   PubMed Web of Science ®Google Scholar
• Harlow, B. L., and N. S. Weiss. 1989. A case-control study of borderline ovarian tumors: The influence of perineal exposure to talc. Am. J. Epidemiol. 130:390–94. doi:10.1093/oxfordjournals.aje.a115345.
   PubMed Web of Science ®Google Scholar
• Hartge, P., R. Hoover, L. P. Lesher, and L. McGowan. 1983. Talc and ovarian cancer (Letter). J Am Med Assoc 25014:1844. doi:10.1001/jama.1983.03340140020020.
   Google Scholar
• Heller, D. S., C. Westhoff, R. E. Gordon, and N. Katz. 1996. The relationship between perineal cosmetic talc usage and ovarian talc particle burden. Am. J. Obstet. Gynecol. 174:1507–10. doi:10.1016/S0002-9378(96)70597-5.
   PubMed Web of Science ®Google Scholar
• Henderson, W. J., T. C. Hamilton, M. S. Baylis, C. G. Pierrepoint, and K. Griffiths. 1986. The demonstration of the migration of talc from the vagina and posterior uterus to the ovary in the rat. Environ. Res. 40:247–50. doi:10.1016/S0013-9351(86)80100-1.
   PubMed Web of Science ®Google Scholar
• Henderson, W. J., T. C. Hamilton, and K. Griffiths. 1979. Talc in normal and malignant ovarian tissue (Letter). Lancet 1:499. doi:10.1016/S0140-6736(79)90861-4.
   PubMed Web of Science ®Google Scholar
• Henderson, W. J., C. A. Joslin, A. C. Turnbull, and K. Griffiths. 1971. Talc and carcinoma of the ovary and cervix. J. Obstet. Gynaecol. Br. Commonwealth. 78:266–72. doi:10.1111/j.1471-0528.1971.tb00267.x.
   PubMedGoogle Scholar
• Houghton, S. C., K. W. Reeves, S. E. Hankinson, L. Crawford, D. Lane, J. Wactawski-Wende, C. A. Thomson, J. K. Ockene, and S. R. Sturgeon. 2014. Perineal powder use and risk of ovarian cancer. J. Natl. Cancer Inst. 106:dju208. doi:10.1093/jnci/dju208.
   PubMedGoogle Scholar
• Huncharek, M., J. F. Geschwind, and B. Kupelnick. 2003. Perineal application of cosmetic talc and risk of invasive epithelial ovarian cancer: A meta-analysis of 11,933 subjects from sixteen observational studies. Anticancer Res. 23:1955–60.
   PubMed Web of Science ®Google Scholar
• Huncharek, M., and J. Muscat. 2011. Perineal talc use and ovarian cancer risk: A case study of scientific standards in environmental epidemiology. Eur. J. Cancer Prev. 20:501–07. doi:10.1097/CEJ.0b013e3283476242.
   PubMed Web of Science ®Google Scholar
• Huncharek, M., J. Muscat, A. Onitilo, and B. Kupelnick. 2007. Use of cosmetic talc on contraceptive diaphragms and risk of ovarian cancer: A meta-analysis of nine observational studies. Eur. J. Cancer Prev. 16:422–29. doi:10.1097/01.cej.0000236257.03394.4a.
   PubMed Web of Science ®Google Scholar
• Hunn, J., and G. C. Rodriguez. 2012. Ovarian cancer: Etiology, risk factors and epidemiology. Clin. Obstet. Gynecol. 55:3–23. doi:10.1097/GRF.0b013e31824b4611.
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer (IARC). 1991. IARC monographs on the evaluation of carcinogenic risks to humans volume 51: Coffee, tea, mate, methylxanthines and methylglyoxal, IARC Monograph No. 51, 523. Geneva, Switzerland: World Health Organization (WHO).
   Google Scholar
• International Agency for Research on Cancer (IARC). 2010. IARC monographs on the evaluation of carcinogenic risks to humans volume 93: Carbon black, titanium dioxide, and talc, 466. Lyon, France: International Agency for Research on Cancer (IARC); World Health Organization (WHO). IARC Monograph No. 93. http://monographs.iarc.fr/ENG/Monographs/vol100C/mono93.pdf.
   Google Scholar
• International Agency for Research on Cancer (IARC). 2018. IARC monographs on the evaluation of carcinogenic risks to humans volume 116: Drinking coffee, tea, mate, and very hot beverages. Lyon, France: International Agency for Research on Cancer (IARC) World Health Organization (WHO), Geneva, Switzerland. IARC Monograph No. 116, 508.
   Google Scholar
• Jelovac, D., and D. K. Armstrong. 2011. Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J. Clin. 61:183–203. doi:10.3322/caac.20113.
   PubMed Web of Science ®Google Scholar
• Jordan, S. J., A. C. Green, D. C. Whiteman, and P. M. Webb. 2007. Risk factors for benign serous and mucinous epithelial ovarian tumors. Obstet. Gynecol. 106:647–54. doi:10.1097/01.AOG.0000254159.75977.fa.
   Google Scholar
• Jurek, A. M., S. Greenland, G. Maldonado, and T. R. Church. 2005. Proper interpretation of non-differential misclassification effects: Expectations vs observations. Int. J. Epidemiol. 34:680–87. doi:10.1093/ije/dyi060.
   PubMed Web of Science ®Google Scholar
• Jurek, A. M., G. Maldonado, S. Greenland, and T. R. Church. 2006. Exposure-measurement error is frequently ignored when interpreting epidemiologic study results. Eur. J. Epidemiol. 21:871–76. doi:10.1007/s10654-006-9083-0.
   PubMed Web of Science ®Google Scholar
• Keskin, N., Y. A. Teksen, E. G. Ongun, Y. Ozay, and H. Saygili. 2009. Does long-term talc exposure have a carcinogenic effect on the female genital system of rats? An experimental pilot study. Arch. Gynecol. Obstet. 280:925–31. doi:10.1007/s00404-009-1030-3.
   PubMed Web of Science ®Google Scholar
• Kunz, G., D. Beil, H. Deininger, L. Wildt, and G. Leyendecker. 1996. The dynamics of rapid sperm transport through the female genital tract: Evidence from vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy. Human Reprod. 11:627–32. doi:10.1093/HUMREP/11.3.627.
   PubMed Web of Science ®Google Scholar
• Kurta, M., K. B. Moysich, J. L. Weissfeld, A. O. Youk, C. H. Bunker, R. P. Edwards, F. Modugno, R. B. Ness, and B. Diergaarde. 2012. Use of fertility drugs and risk of ovarian cancer: Results from a U.S.-based case-control study. Cancer Epidemiol. Biomarkers Prev. 21 (8):1282–92. doi:10.1158/1055-9965.EPI-12-0426.
   PubMed Web of Science ®Google Scholar
• La Vecchia, C. 2017. Ovarian cancer: Epidemiology and risk factors. Eur. J. Cancer Prev. 26:55–62. doi:10.1097/CEJ.0000000000000217.
   PubMed Web of Science ®Google Scholar
• Langseth, H., S. E. Hankinson, J. Siemiatycki, and E. Weiderpass. 2008. Perineal use of talc and risk of ovarian cancer. J. Epidemiol. Community Health 62:358–60. doi:10.1136/jech.2006.047894.
   PubMed Web of Science ®Google Scholar
• Langseth, H., and K. Kjaerheim. 2004. Ovarian cancer and occupational exposure among pulp and paper employees in Norway. Scand. J. Work Environ. Health 30:256–361. doi:10.5271/sjweh.823.
   Web of Science ®Google Scholar
• Lash, T. L., M. P. Fox, and A. K. Fink. 2009. Applying quantitative bias analysis to epidemiologic data. New York, NY: Springer.
   Google Scholar
• Lash, T. L., M. P. Fox, R. F. MacLehose, G. Maldonado, L. C. McCandless, and S. Greenland. 2014. Good practices for quantitative bias analysis. Int. J. Epidemiol. 43:1969–85. doi:10.1093/ije/dyu149.
   PubMed Web of Science ®Google Scholar
• Lemen, R. A. 2016. Mesothelioma from asbestos exposures: Epidemilogic patters and impact in the United States. J. Toxicol Environ. Health B 19:250–65. doi:10.1080/10937404.2016.1195323.
   PubMed Web of Science ®Google Scholar
• Lukanova, A., and R. Kaaks. 2005. Endogenous hormones and ovarian cancer: Epidemiology and current hypotheses. Cancer Epidemiol. Biomarkers Prev. 14:98–107.
   PubMed Web of Science ®Google Scholar
• Mandarino, A., D. J. Gregory, C. C. McGuire, B. W. Leblanc, H. Witt, L. M. Rivera, J. J. Godleski, and A. V. Fedulov. 2020. The effect of talc particles on phagocytes in co-culture with ovarian cancer cells. Environ. Res. 180:108676. doi:10.1016/j.envres.2019.108676.
   PubMed Web of Science ®Google Scholar
• Mayo Clinic. 2019. Ovarian cancer: Symptoms & causes. July 25. https://www.mayoclinic.org/diseases-conditions/ovarian-cancer/symptoms-causes/syc-20375941.
   Google Scholar
• McDonald, S. A., Y. Fan, W. R. Welch, D. W. Cramer, and J. J. Godleski. 2019b. Migration of talc from the perineum to multiple pelvic organ sites. Am. J. Clin. Pathol. 152:590–607. doi:10.1093/ajcp/aqz080.
   PubMed Web of Science ®Google Scholar
• McDonald, S. A., Y. Fan, W. R. Welch, D. W. Cramer, R. C. Stearns, L. Sheedy, M. Katler, and J. J. Godleski. 2019a. Correlative polarizing light and scanning electron microscopy for the assessment of talc in pelvic region lymph nodes. Ultrastruct. Pathol. 43:13–27. doi:10.1080/01913123.2019.1593271.
   PubMed Web of Science ®Google Scholar
• Memorial Sloan Kettering Cancer Center. 2019. Ovarian cancer. https://www.mskcc.org/cancer-care/types/ovarian.
   Google Scholar
• Merritt, M. A., A. C. Green, C. M. Nagle, and P. M. Webb; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group. 2008. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int. J. Cancer 122:170–76. doi:10.1002/ijc.23017.
   PubMed Web of Science ®Google Scholar
• Mills, P. K., D. G. Riordan, R. D. Cress, and H. A. Young. 2004. Perineal talc exposure and epithelial ovarian cancer risk in the Central Valley of California. Int. J. Cancer 112:458–64. doi:10.1002/ijc.20434.
   PubMed Web of Science ®Google Scholar
• Moorman, P. G., R. T. Palmieri, L. Akushevich, A. Berchuck, and J. M. Schildkraut. 2009. Ovarian cancer risk factors in African-American and white women. Am. J. Epidemiol. 170:598–606. doi:10.1093/aje/kwp176.
   PubMed Web of Science ®Google Scholar
• Mostafa, S. A., C. B. Bargeron, R. W. Flower, N. B. Rosenshein, T. H. Parmley, and J. D. Woodruff. 1985. Foreign body granulomas in normal ovaries. Obstet. Gynecol. 66:701–02.
   PubMed Web of Science ®Google Scholar
• Murphy, F. A., A. Schinwald, C. A. Poland, and K. Donaldson. 2012. The mechanism of pleural inflammation by long carbon nanotubes: Interaction of long fibres with macrophages stimulates them to amplify pro-inflammatory responses in mesothelial cells. Part. Fibre Toxicol. 9:8. doi:10.1186/1743-8977-9-8.
   PubMed Web of Science ®Google Scholar
• Muscat, J. E., and M. S. Huncharek. 2008. Perineal talc use and ovarian cancer: A critical review. Eur. J. Cancer Prev. 17:139–46. doi:10.1097/CEJ.0b013e32811080ef.
   PubMed Web of Science ®Google Scholar
• Musser, S. M., [US Food and Drug Administration (US FDA)]. 2014. Letter to S. Epstein (University of Illinois, Chicago) [re: Response to Citizen Petitions requesting that the Food and Drug Administration (FDA) require a cancer warning on cosmetic talc products]. 94P-0420, FDA-2008-P-0309-0001/CP, 7p., April 1.
   Google Scholar
• National Cancer Institute (NCI). 2016. Ovarian, fallopian tube, and primary peritoneal cancer prevention (PDQ) - Professional version. February 4. http://www.cancer.gov/types/ovarian/hp/ovarian-prevention-pdq.
   Google Scholar
• National Institute for Occupational Safety and Health (NIOSH). 2011. Asbestos fibers and other elongate mineral particles: State of the science and roadmap for research (Revised Edition). DHHS (NIOSH) Publication No. 2011-159, NIOSH Current Intelligence Bulletin 62, 174p., April. Accessed July 30, 2018 https://www.cdc.gov/niosh/docs/2011-159/pdfs/2011-159.pdf?id=10.26616/NIOSHPUB2011159.
   Google Scholar
• National Toxicology Program (NTP). 1993. Toxicology and carcinogenesis studies of talc (CAS NO. 14807-96-6) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). NTP Technical Report Series No. 421, NIH Publication No. 93-3152, 287p., September.
   Google Scholar
• Ness, R. B., and C. Cottreau. 1999. Possible role of ovarian epithelial inflammation in ovarian cancer. J. Natl. Cancer Inst. 91:1459–67. doi:10.1093/jnci/91.17.1459.
   PubMed Web of Science ®Google Scholar
• Ness, R. B., J. A. Grisso, C. Cottreau, J. Klapper, R. Vergona, J. E. Wheeler, M. Morgan, and J. J. Schlesselman. 2000. Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology 11:111–17. doi:10.1097/00001648-200003000-00006.
   PubMed Web of Science ®Google Scholar
• O’Brien, K. M., S. S. Tworoger, H. R. Harris, G. L. Anderson, C. R. Weinberg, B. Trabert, A. M. Kaunitz, A. A. D’Aloisio, D. P. Sandler, and N. Wentzensen. 2020. Association of powder use in the genital area with risk of ovarian cancer. J Am Med Assoc 323:49–59. doi:10.1001/jama.2019.20079.
   PubMed Web of Science ®Google Scholar
• Oberdorster, G. 1995. The NTP talc inhalation study: A critical appraisal focused on lung particle overload. Regul. Toxicol. Pharmacol. 21:233–41. doi:10.1006/rtph.1995.1034.
   PubMed Web of Science ®Google Scholar
• Ozesmi, M., T. E. Patiroglu, G. Hillerdal, and C. Ozesmi. 1985. Peritoneal mesothelioma and malignant lymphoma in mice caused by fibrous zeolite. Br. J. Ind. Med. 42:746–49. doi:10.1136/oem.42.11.746.
   PubMedGoogle Scholar
• Penninkilampi, R., and G. D. Eslick. 2018. Perineal talc use and ovarian cancer: A systematic review and meta-analysis. Epidemiology 29:41–49. doi:10.1097/EDE.0000000000000745.
   PubMed Web of Science ®Google Scholar
• Phillips, J. C., P. J. Young, K. Hardy, and S. D. Gangolli. 1978. Studies on the absorption and disposition of 3H-labelled talc in the rat, mouse, guinea-pig and rabbit. Food Cosmet. Toxicol. 16:161–63. doi:10.1016/S0015-6264(78)80197-7.
   PubMedGoogle Scholar
• Pott, F., F. Huth, and K. H. Friedrichs. 1974. Tumorigenic effect of fibrous dusts in experimental animals. Environ. Health Perspect. 9:313–15. doi:10.1289/ehp.749313.
   PubMedGoogle Scholar
• Purdie, D., A. Green, C. Bain, V. Siskind, B. Ward, N. Hacker, M. Quinn, G. Wright, P. Russell, and B. Susil. 1995. Reproductive and other factors and risk of epithelial ovarian cancer: An Australian case-control study. Survey of women’s health study group. Int. J. Cancer 62:676–84. doi:10.1002/ijc.2910620606.
   Web of Science ®Google Scholar
• Purdie, D. M., C. J. Bain, V. Siskind, P. M. Webb, and A. C. Green. 2003. Ovulation and risk of epithelial ovarian cancer. Int. J. Cancer 104:228–32. doi:10.1002/ijc.10927.
   PubMed Web of Science ®Google Scholar
• Rosenblatt, K. A., M. Szklo, and N. B. Rosenshein. 1992. Mineral fiber exposure and the development of ovarian cancer. Gynecol. Oncol. 45:20–25. doi:10.1016/0090-8258(92)90485-2.
   PubMed Web of Science ®Google Scholar
• Rosenblatt, K. A., N. S. Weiss, K. L. Cushing-Haugen, K. G. Wicklund, and M. A. Rossing. 2011. Genital powder exposure and the risk of epithelial ovarian cancer. Cancer Causes Control 22:737–42. doi:10.1007/s10552-011-9746-3.
   PubMed Web of Science ®Google Scholar
• Rosenman, K. D. 2012. Talc. In Patty’s toxicology, ed. E. Bingham, and B. Cohrssen, 257–72. 6th ed. Hoboken, NJ: John Wiley & Sons, Inc..
   Google Scholar
• Rothman, K. J., S. Greenland, and T. L. Lash. 2008. Case-control studies. In Modern epidemiology, 111–27. 3rd ed. (Rothman, KJ; Greenland, S; Lash, TL). Philadelphia, PA: Lippincott Williams & Wilkins.
   Google Scholar
• Rothman, K. J., H. Pastides, and J. Samet. 2000. Interpretation of epidemiologic studies on talc and ovarian cancer, 11., November 28.
   Google Scholar
• Sahu, A. P., R. Shanker, and S. H. Zaidi. 1978. Pulmonary response to kaolin, mica and talc in mice. Exp. Pathol. 16:276–82. doi:10.1016/S0014-4908(78)80031-3.
   Google Scholar
• Schildkraut, J. M., S. E. Abbott, A. J. Alberg, E. V. Bandera, J. S. Barnholtz-Sloan, M. L. Bondy, M. L. Cote, E. Funkhouser, L. C. Peres, E. S. Peters, et al. 2016. Association between body powder use and ovarian cancer: The African American cancer epidemiology study (AACES). Canccer Epidemiol. Biomarkers Prev. 25:1411–17. doi:10.1158/1055-9965.EPI-15-1281.
   PubMed Web of Science ®Google Scholar
• Sjosten, A. C., H. Ellis, and G. A. Edelstam. 2004. Retrograde migration of glove powder in the human female genital tract. Human Reprod. 19:991–95. doi:10.1093/humrep/deh156.
   PubMed Web of Science ®Google Scholar
• Stanton, M. F., M. Layard, A. Tegeris, E. Miller, M. May, E. Morgan, and A. Smith. 1981. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J. Natl. Cancer Inst. 67:965–75.
   PubMed Web of Science ®Google Scholar
• Stenback, F., and J. Rowland. 1978. Role of talc and benzo(a)pyrene in respiratory tumor formation. An experimental study. Scand. J. Respir. Dis. 59:130–40.
   PubMedGoogle Scholar
• Sueblinvong, T., and M. E. Carney. 2009. Current understanding of risk factors for ovarian cancer. Curr. Treat. Options Oncol. 10:68–87. doi:10.1007/s11864-009-0108-2.
   Web of Science ®Google Scholar
• Taher, M. K., N. Farhat, N. A. Karyakina, N. Shilnikova, S. Ramoju, C. A. Gravel, K. Krishnan, D. Mattison, S. W. Wen, and D. Krewski. 2019. Critical review of the association between perineal use of talc powder and risk of ovarian cancer. Reprod. Toxicol. 90:88–101. doi:10.1016/j.reprotox.2019.08.015.
   PubMed Web of Science ®Google Scholar
• Terry, K. L., S. Karageorgi, Y. B. Shvetsov, M. A. Merritt, G. Lurie, P. J. Thompson, M. E. Carney, R. P. Weber, L. Akushevich, W. H. Lo-Ciganic, et al. 2013. Genital powder use and risk of ovarian cancer: A pooled analysis of 8,525 cases and 9,859 controls. Cancer Prev. Res. 6:811–21. doi:10.1158/1940-6207.CAPR-13-0037.
   PubMed Web of Science ®Google Scholar
• Tzonou, A., A. Polychronopoulou, C. C. Hsieh, A. Rebelakos, A. Karakatsani, and D. Trichopoulos. 1993. Hair dyes, analgesics, tranquilizers and perineal talc application as risk factors for ovarian cancer. Int. J. Cancer 55:408–10. doi:10.1002/ijc.2910550313.
   PubMed Web of Science ®Google Scholar
• Urban, N., S. Hawley, H. Janes, B. Y. Karlan, C. D. Berg, C. W. Drescher, J. E. Manson, M. R. Palomares, M. B. Daly, J. Wactawski-Wende, et al. 2015. Identifying post-menopausal women at elevated risk for epithelial ovarian cancer. Gynecol. Oncol. 139:253–60. doi:10.1016/j.ygyno.2015.08.024.
   PubMed Web of Science ®Google Scholar
• Venter, P. F., and M. Iturralde. 1979. Migration of a particulate radioactive tracer from the vagina to the peritoneal cavity and ovaries. S. Afr. Med. J. 55:917–99.
   PubMed Web of Science ®Google Scholar
• Vrijheid, M., E. Cardis, B. K. Armstrong, A. Auvinen, G. Berg, K. G. Blaasaas, J. Brown, M. Carroll, A. Chetrit, H. C. Christensen, et al. 2006. Validation of short term recall of mobile phone use for the Interphone study. Occup. Environ. Med. 63:237–43. doi:10.1136/oem.2004.019281.
   PubMed Web of Science ®Google Scholar
• Wagner, J. C., G. Berry, T. J. Cooke, R. J. Hill, F. D. Pooley, and J. W. Skidmore. 1977. Animal experiments with talc. Inhaled Part 4 (pt. 2):647–54. In Inhaled Particles. IV. Proceedings of an International Symposium Organized by the British Occupational Hygiene Society, held September 22-26. (Eds.: Walton, WH; McGovern, B), Pergamon Press.
   Google Scholar
• Walsh, T., S. Casadei, M. K. Lee, C. C. Pennil, A. S. Nord, A. M. Thornton, W. Roeb, K. J. Agnew, S. M. Stray, A. Wickramanayake, et al. 2011. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc. Natl. Acad. Sci. USA. 108:10832–37. doi:10.1073/pnas.1115052108.
   Web of Science ®Google Scholar
• Wehner, A. P. 2002. Cosmetic talc should not be listed as a carcinogen: Comments on NTP’s deliberations to list talc as a carcinogen. Regul. Toxicol. Pharmacol. 36:40–50. doi:10.1006/rtph.2002.1560.
   PubMed Web of Science ®Google Scholar
• Wehner, A. P., A. S. Hall, R. E. Weller, E. A. Lepel, and R. E. Schirmer. 1985. Do particles translocate from the vagina to the oviducts and beyond? Food Chem. Toxicol. 23:367–72. doi:10.1016/0278-6915(85)90073-0.
   PubMed Web of Science ®Google Scholar
• Wehner, A. P., R. E. Weller, and E. A. Lepel. 1986. On talc translocation from the vagina to the oviducts and beyond. Food Chem. Toxicol. 24:329–38. doi:10.1016/0278-6915(86)90011-6.
   PubMed Web of Science ®Google Scholar
• Wehner, A. P., G. M. Zwicker, and W. C. Cannon. 1977. Inhalation of talc baby powder by hamsters. Food Cosmet. Toxicol. 15:121–29. doi:10.1016/S0015-6264(77)80317-9.
   PubMedGoogle Scholar
• Wentzensen, N., and S. Wacholder. 2014. Talc use and ovarian cancer: Epidemiology between a rock and a hard place. J. Natl. Cancer Inst. 106 (dju260). doi: 10.1093/jnci/dju260.
   Google Scholar
• Whittemore, A. S., M. L. Wu, R. S. Paffenbarger Jr, D. L. Sarles, J. B. Kampert, S. Grosser, D. L. Jung, S. Ballon, and M. Hendrickson. 1988. Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee. Am. J. Epidemiol. 128:1228–40. doi:10.1093/oxfordjournals.aje.a115077.
   PubMed Web of Science ®Google Scholar
• Williams, K. A., S. I. Labidi-Galy, K. L. Terry, A. F. Vitonis, W. R. Welch, A. Goodman, and D. W. Cramer. 2014. Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer. Gynecol. Oncol. 132:542–50. doi:10.1016/j.ygyno.2014.01.026.
   PubMed Web of Science ®Google Scholar
• Wong, C., R. E. Hempling, M. S. Piver, N. Natarajan, and C. J. Mettlin. 1999. Perineal talc exposure and subsequent epithelial ovarian cancer: A case-control study. Obstet. Gynecol. 93:372–76. doi:10.1016/s0029-7844(98)00439-6.
   PubMed Web of Science ®Google Scholar
• Wu, A. H., C. L. Pearce, C. C. Tseng, and M. C. Pike. 2015. African Americans and Hispanics remain at lower risk of ovarian cancer than non-Hispanic whites after considering nongenetic risk factors and oophorectomy rates. Cancer Epidemiol. Biomarkers Prev. 24:1094–100. doi:10.1158/1055-9965.EPI-15-0023.
   PubMed Web of Science ®Google Scholar
• Wu, A. H., C. L. Pearce, C. C. Tseng, C. Templeman, and M. C. Pike. 2009. Markers of inflammation and risk of ovarian cancer in Los Angeles County. Int. J. Cancer 124:1409–15. doi:10.1002/ijc.24091.
   PubMed Web of Science ®Google Scholar